Choose your location:

Choose a Language

Contact us

News Center

Discover all of the trending news of the Ipsen Group


155 results

Event

Exelixis Announces U.S. FDA Accepts Supplemental New Drug Ap...
30 May 2018
__Plan de travail 3 copie 34@2x

Access the press release on Exelixis’ website 

See more
Event

IPSEN SPONSORS THE STROKE ACTION PLAN FOR EUROPE (2018-2030)
22 May 2018
__Plan de travail 3 copie 34@2x

On May 23rd, the Stroke Alliance for Europe (SAFE) and the European Stroke Organization (ESO)…

See more
People

Ipsen Named One of the Best Workplaces in Ireland
19 March 2018
__Plan de travail 3 copie 34@2x

Ipsen was recognised as the 12th Best Medium Workplace in Ireland 2018. The Great Place…

See more
Neuroscience

LivingWithNETs.com awarded as Most valuable patient initiati...
19 March 2018
__Plan de travail 3 copie 34@2x

LivingWithNETs.com is a dedicated website for patients living with neuroendocrine tumors that was designed with…

See more
Oncology

Exelixis Submits U.S. Supplemental New Drug Application for ...
15 March 2018
__Plan de travail 3 copie 34@2x

Access to the press release on Exelixis' website 

See more
Patient

International Childhood Cancer Day, Ipsen mobilizes its team...
15 February 2018
__Plan de travail 3 copie 34@2x

The premise is that all children, no matter what their background, have dreams and aspirations.…

See more
Financial information

Ipsen’s Full Year 2017 Financial Results
14 February 2018
__Plan de travail 3 copie 34@2x

DAVID MEEK, CEO AYMERIC LE CHATELIER, EXECUTIVE VICE PRESIDENT, FINANCE WILL BE PRESENTING IPSEN’S FULL…

See more
Oncology

Ipsen and Exelixis to host joint investor briefing on Phase ...
15 January 2018
__Plan de travail 3 copie 34@2x

Ipsen and its partner Exelixis will jointly host a live investor briefing at the 2018…

See more
Oncology

Ipsen at ASCO GI 2018
15 January 2018
__Plan de travail 3 copie 34@2x

We are excited to be participating in the 2018 ASCO GI congress in San Francisco…

See more
Event

Ipsen to present at the J.P. Morgan Healthcare Conference &#...
04 January 2018
__Plan de travail 3 copie 34@2x

David Meek, CEO will present at the J.P. Morgan Healthcare Conference  in San Francisco, California…

See more
People

Ipsen wishes you the best for 2018
29 December 2017
__Plan de travail 3 copie 34@2x

See more
Oncology

Ipsen’s partner Exelixis announces U.S. FDA approval o...
20 December 2017
__Plan de travail 3 copie 34@2x

RCC is the most common form of kidney cancer in adults. The FDA’s priority…

See more
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023